Ukrainian Drone Strike Ignites Fire at Key Russian Oil Export Terminal Escalating Energy Infrastructure Risks Trek 2000 Secures New Investor as Osim Founder Ron Sim Drops Legal Claims Sells Stake at Premium AIDriven Drug Discovery May Accelerate Treatments for Brain Conditions Like MND Fed Rate Hike Expectations Return as Traders Price in Move by December After Inflation Surge Aequs Reports 54 Crore Net Loss in Q4FY26 Amid Strong Aerospace Segment Growth Retail Chain to Close All Stores After 33 Years of Operations BULL Q1 2026 Earnings EPS Misses Estimates by Over 50 Stock Declines MTB Q1 2026 Earnings Earnings Beat Estimates as Net Interest Income Holds Steady FTI Q1 2026 Earnings EPS Surges Past Estimates Despite Stock Dip NRSN Q2 2025 Earnings Narrower Loss Surprises Shares Gain on Cost Discipline CRK Q1 2026 Earnings Earnings Miss Expectations Amid Challenging Natural Gas Environment FCX Q1 2026 Earnings Strong Earnings Beat Amid Robust Copper Demand Alarum Technologies ALAR Surges 298 as Shares Test Key Resistance Alpha and Omega Semiconductor AOSL Surges 667 on Strong Volume Key Levels to Watch CeriBell CBLL Edges Lower Hovers Near Support Amid Modest Decline Prenetics Global PRE Dips 174 as Stock Hovers Near Key Support Zone Blackrock Enhanced Global Dividend Trust BOE Inches Higher as Income Investors Seek Stability Broadcoms 2 Trillion Valuation The Custom Chip Economics Dilemma Trane Technologies Q1 2026 Earnings EPS Beats Estimates Amid Strong Operational Performance Rigel Pharmaceuticals RIGL Gains Nearly 2 as Stock Tests Key Resistance Near 3124 ADT Q1 2026 Earnings EPS Surpasses Estimates Despite Stock Decline IMRX Q1 2026 Earnings EPS Surpasses Estimates as Clinical Pipeline Advances Lamb Weston LW Q1 2026 Earnings EPS Surpasses Estimates as Shares Gain Ground AVD Q3 2025 Earnings Significant EPS Miss Weighs on Shares Quoin Pharmaceuticals Ltd Q1 2026 Earnings NarrowerThanExpected Loss Amid PreRevenue Phase AIRE Q1 2026 Earnings NarrowerThanExpected Loss Fails to Lift Stock Instil Bio Inc TIL Q1 2026 Earnings WiderThanExpected Loss as Biotech Continues PreCommercial Phase